【ワシントンＡＦＰ＝時事】米食品医薬品局（ＦＤＡ）は２０日、新型コロナウイルスワクチンの追加接種を６５歳以上、または深刻な基礎疾患がある人に制限する方針を示した。６５歳未満で基礎疾患のない個人に関しては、ワクチンを製造する製薬会社に新たな臨床試験の実 ...

健康な成人と子どもを対象とした新型コロナウイルス感染症のブースター接種について、米規制当局は今後、新たな臨床試験で安全性と有効性が確認されることを承認の条件とする。コストのかかる新要件が追加され、将来的にはワクチン接種対象者が絞られる可能性もある。

（ＣＮＮ） 米食品医薬品局（ＦＤＡ）は、新型コロナウイルスのワクチン接種に伴って稀（まれ）に起きる心疾患のリスクについて、警告表示を拡大してリスクに関する情報量を増やすことをメーカーに義務付ける。

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

Changes are on the way to COVID vaccines, thanks to a new policy by the Trump administration. The changes by the FDA mean ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The FDA is forcing Pfizer and Moderna to expand warning labels about the risks of two forms of heart damage, myocarditis and ...

The Food and Drug Administration (FDA) will now take a different approach to protecting Americans against COVID-19, limiting ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...